APPLICATION
ANDA201894
TYPE
ANDA
ORIGINAL APPROVAL
2014-12-01
LATEST ACTION
2022-08-03
ROUTE
TOPICAL
DOSAGE FORM
SOLUTION/DROPS
MARKETING STATUS
Discontinued
Products
BIMATOPROSTDiscontinued
BIMATOPROST 0.03% · SOLUTION/DROPS · TOPICAL
Approval history
2022-08-03Labeling · Supplement 4 · standardAP
2022-08-03Labeling · Supplement 5 · standardAP
2018-12-10Manufacturing (CMC) · Supplement 3 · unknownAP
2014-12-01Not Applicable · OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.